Boston Scientific announces upcoming investor conference schedule
Boston Scientific (NYSE: BSX) has announced its participation in two major investor conferences in May 2025. At the Bank of America's 2025 Health Care Conference on May 13, Dan Brennan (EVP & CFO) and Joe Fitzgerald (EVP & Group President, Cardiology) will engage in a 30-minute Q&A session starting at 8:00 a.m. PT. Later, on May 28, at Bernstein's 41st Annual Strategic Decisions Conference, Chairman & CEO Mike Mahoney and Dr. Ken Stein (SVP & Global Chief Medical Officer) will participate in a 50-minute Q&A session beginning at 8:00 a.m. ET. Both events will be available via live webcast and replay on the company's investor relations website.
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. Il 13 maggio, durante la Bank of America's 2025 Health Care Conference, Dan Brennan (EVP e CFO) e Joe Fitzgerald (EVP e Presidente del Gruppo Cardiologia) parteciperanno a una sessione di domande e risposte di 30 minuti a partire dalle 8:00 PT. Successivamente, il 28 maggio, alla 41陋 Conferenza Annuale sulle Decisioni Strategiche di Bernstein, il Presidente e CEO Mike Mahoney e il Dr. Ken Stein (SVP e Chief Medical Officer Globale) prenderanno parte a una sessione Q&A di 50 minuti dalle 8:00 ET. Entrambi gli eventi saranno trasmessi in diretta streaming e disponibili in replica sul sito web delle relazioni con gli investitori della societ脿.
Boston Scientific (NYSE: BSX) ha anunciado su participaci贸n en dos importantes conferencias para inversores en mayo de 2025. El 13 de mayo, en la Conferencia de Atenci贸n M茅dica 2025 de Bank of America, Dan Brennan (EVP y CFO) y Joe Fitzgerald (EVP y Presidente del Grupo de Cardiolog铆a) participar谩n en una sesi贸n de preguntas y respuestas de 30 minutos a partir de las 8:00 a.m. PT. M谩s tarde, el 28 de mayo, en la 41陋 Conferencia Anual de Decisiones Estrat茅gicas de Bernstein, el presidente y CEO Mike Mahoney y el Dr. Ken Stein (SVP y Director M茅dico Global) participar谩n en una sesi贸n de preguntas y respuestas de 50 minutos a partir de las 8:00 a.m. ET. Ambos eventos estar谩n disponibles mediante webcast en vivo y repetici贸n en el sitio web de relaciones con inversores de la compa帽铆a.
Boston Scientific (NYSE: BSX)電� 2025雲� 5鞗旍棎 鞐措Μ電� 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 5鞗� 13鞚�鞐� 鞐措Μ電� Bank of America 2025 項姢旒�鞏� 旎嵓霟办姢鞐愳劀 Dan Brennan (EVP 瓴� CFO)瓿� Joe Fitzgerald (EVP 瓴� 鞁灔頃� 攴鸽９ 靷灔)臧� 鞓れ爠 8鞁�(韮滍弶鞏� 響滌鞁�)攵�韯� 30攵勱皠 Q&A 靹胳厴鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 鞚挫柎靹� 5鞗� 28鞚�鞐愲姅 Bernstein鞚� 鞝�41須� 鞐半 鞝勲灥鞝� 瓴办爼 旎嵓霟办姢鞐愳劀 須岇灔 瓴� CEO Mike Mahoney鞕� Dr. Ken Stein (SVP 瓴� 旮�搿滊矊 斓滉碃 鞚橂 毂呾瀯鞛�)鞚� 鞓れ爠 8鞁�(霃欕秬 響滌鞁�)攵�韯� 50攵勱皠 Q&A 靹胳厴鞐� 彀胳棳頃╇媹雼�. 霊� 頄夓偓 氇憪 須岇偓 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞁れ嫓臧� 鞗轨簮鞀ろ姼 氚� 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�.
Boston Scientific (NYSE : BSX) a annonc茅 sa participation 脿 deux grandes conf茅rences pour investisseurs en mai 2025. Le 13 mai, lors de la Bank of America's 2025 Health Care Conference, Dan Brennan (EVP et CFO) et Joe Fitzgerald (EVP et Pr茅sident du groupe Cardiologie) animeront une session de questions-r茅ponses de 30 minutes 脿 partir de 8h00 PT. Ensuite, le 28 mai, lors de la 41e conf茅rence annuelle sur les d茅cisions strat茅giques de Bernstein, le pr茅sident-directeur g茅n茅ral Mike Mahoney et le Dr Ken Stein (SVP et directeur m茅dical mondial) participeront 脿 une session de questions-r茅ponses de 50 minutes 脿 partir de 8h00 ET. Les deux 茅v茅nements seront diffus茅s en direct par webcast et disponibles en replay sur le site des relations investisseurs de la soci茅t茅.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 bekanntgegeben. Am 13. Mai werden Dan Brennan (EVP & CFO) und Joe Fitzgerald (EVP & Gruppenpr盲sident Kardiologie) auf der Bank of America 2025 Health Care Conference an einer 30-min眉tigen Fragerunde ab 8:00 Uhr PT teilnehmen. Sp盲ter, am 28. Mai, nehmen Chairman & CEO Mike Mahoney und Dr. Ken Stein (SVP & Global Chief Medical Officer) an der 50-min眉tigen Fragerunde auf Bernsteins 41. j盲hrlicher Strategic Decisions Conference ab 8:00 Uhr ET teil. Beide Veranstaltungen werden live per Webcast 眉bertragen und sind anschlie脽end auf der Investor-Relations-Webseite des Unternehmens verf眉gbar.
- None.
- None.
On May 13, 2025, Dan Brennan, executive vice president and chief financial officer, and Joe Fitzgerald, executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET.
On May 28, 2025, Mike Mahoney, chairman and chief executive officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 50-minute question-and-answer session with the host analyst at Bernstein's 41st Annual Strategic Decisions Conference. The session will begin at approximately 8:00 a.m. ET.
A live webcast and replay for each event will be accessible at . The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com听and connect on and . 听
CONTACTS:
Chanel Hastings
Media Relations
(508) 382-0288 (office)
[email protected]听
Jon Monson
Investor Relations
+1 (508) 683-5450
[email protected]听
View original content to download multimedia:
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) presenting at the Bank of America Health Care Conference 2025?
Who will represent BSX at Bernstein's Strategic Decisions Conference in May 2025?
How can investors access Boston Scientific's conference presentations in May 2025?
What is the duration of BSX's Q&A session at Bernstein's conference?
